An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples